| Literature DB >> 33572655 |
Siqi Li1, Kazuko Tajiri1, Nobuyuki Murakoshi1, DongZhu Xu1, Saori Yonebayashi1, Yuta Okabe1, Zixun Yuan1, Duo Feng1, Keiko Inoue1, Kazuhiro Aonuma1, Yuzuno Shimoda1, Zoughu Song1, Haruka Mori1, Honglan Huang2, Kazutaka Aonuma1, Masaki Ieda1.
Abstract
Programmed death ligand 2 (PD-L2) is the second ligand of programmed death 1 (PD-1) protein. In autoimmune myocarditis, the protective roles of PD-1 and its first ligand programmed death ligand 1 (PD-L1) have been well documented; however, the role of PD-L2 remains unknown. In this study, we report that PD-L2 deficiency exacerbates myocardial inflammation in mice with experimental autoimmune myocarditis (EAM). EAM was established in wild-type (WT) and PD-L2-deficient mice by immunization with murine cardiac myosin peptide. We found that PD-L2-deficient mice had more serious inflammatory infiltration in the heart and a significantly higher myocarditis severity score than WT mice. PD-L2-deficient dendritic cells (DCs) enhanced CD4+ T cell proliferation in the presence of T cell receptor and CD28 signaling. These data suggest that PD-L2 on DCs protects against autoreactive CD4+ T cell expansion and severe inflammation in mice with EAM.Entities:
Keywords: EAM; PD-L2; autoimmunity; cardio-oncology; immune checkpoint; myocarditis
Year: 2021 PMID: 33572655 PMCID: PMC7866985 DOI: 10.3390/ijms22031426
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923